Michael Frid

Felicitex Therapeutics, Inc. is a pre-clinical stage oncology drug development company developing therapies against cancer and diabetes. It operates through the Felicitex Business and TraMeta segments. The Felicitex Business segment handles the design and patents of small molecules and related methods to selectively disrupt dormant cancer cells in a manner that is specific to the disease and tissue context. The TarMeta segment built a drug discovery platform for small molecule inhibitors targeting cancer. The company was founded by Maria Vilenchik and Michael Frid on May 4, 2012 and is headquartered in Natick, MA.

Manna Molecular Science LLC specializes in sublingual delivery systems for cannabinoids. The private company is based in Pittsfield, MA. The company's proprietary product, Manna SpeedTabs, dissolves under the tongue for rapid delivery of cannabinoids into the bloodstream. The company also offers a line of CBD and THC patches, lotions, and sexual enhancers. The company's products are gluten-free, vegan, and have zero calories. Customers can purchase Manna CBD and CBN products online, including new forms and effects for cannabis enjoyment.

Vella Bioscience, Inc. is a consumer product company that focuses on improving women's sexual wellbeing. The company is based in Worcester, MA. The company operates at the intersection of biotech and wellness and aims to address the specific needs of female bodies. The company's flagship product is the award-winning women's pleasure serum, which is scientifically proven to enhance a woman's arousal and orgasm. Vella Bioscience was founded in 2020 by Michael Frid, Nial C. DeMena, Carolyn Wheeler, and Harin Padma-Nathan, with Carolyn Wheeler serving as the CEO since then.